Who is sponsoring NCT03327766?

NCT03327766 is sponsored by Woman's Health University Hospital, Egypt.

What drugs are being tested in NCT03327766?

Interventions in NCT03327766: 4-Measurment of serum 25(OH)D3 using Vidas by ELFA meathod..

What condition does NCT03327766 study?

NCT03327766 studies vitD3 Level in Cases of Recuurent Pregnancy Loss.

Is NCT03327766 still recruiting?

NCT03327766 is currently status unknown. Last updated 31 October 2017.

Last reviewed 2017-10-31 · How we verify

NCT03327766: vitDinRPL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assesment of Vit D3 Level in Cases of Unexplaind Pregnancy Loss in Assiut

Status unknown Last updated 31 October 2017

What this trial tests

trial testing 4-Measurment of serum 25(OH)D3 using Vidas by ELFA meathod. in vitD3 Level in Cases of Recuurent Pregnancy Loss in 100 participants. Status unknown.

Timeline

1 November 2017

Primary endpoint
30 April 2018

31 October 2018

Quick facts

Lead sponsor	Woman's Health University Hospital, Egypt
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 November 2017
Primary completion	30 April 2018
Estimated completion	31 October 2018

Drugs / interventions tested

4-Measurment of serum 25(OH)D3 using Vidas by ELFA meathod.

Conditions studied

vitD3 Level in Cases of Recuurent Pregnancy Loss — all drugs for vitD3 Level in Cases of Recuurent Pregnancy Loss →

Sponsor

Woman's Health University Hospital, Egypt

Who can join

Adults 20 to 35, female only, with vitD3 Level in Cases of Recuurent Pregnancy Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assesment of Vit D3 leve in cases of unexplained recurrent pregnancy loss in assiut

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Woman's Health University Hospital, Egypt trials

Trials by the same sponsor.

NCT05771922 — Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
NCT05734287 — The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Co · recruiting
NCT04357054 — Darwish Hysteroscopic Test (Hysteroscopic Bubble Suction and Tubal Peristalsis of Darwish Triad) in Myomatous Uterus · NA · unknown
NCT04825041 — Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03327766 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Woman's Health University Hospital, Egypt
Last refreshed: 31 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03327766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing